Mirae Asset Global Investments Co., Ltd. Biotechnology

Mirae Asset Global Investments Co., Ltd.

$28 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
NVO Novo Nordisk A S	$113B	$69.5 Million 0.25% of portfolio	1,006,406	Q2 2025 Reduced 36.88%
VRTX Vertex Pharmaceuticals Inc	$108B	$64.4 Million 0.23% of portfolio	144,588	Q2 2025 Added 0.89%
REGN Regeneron Pharmaceuticals, Inc.	$70.1B	$30 Million 0.11% of portfolio	57,166	Q2 2025 Added 7.69%
MDGL Madrigal Pharmaceuticals, Inc.	$7.52B	$21.4 Million 0.08% of portfolio	70,559	Q2 2025 Added 0.31%
RPRX Royalty Pharma PLC	$16.1B	$3.93 Million 0.01% of portfolio	109,086	Q2 2025 Reduced 4.07%
ZLAB Zai Lab LTD	$2.5B	$2.72 Million 0.01% of portfolio	77,857	Q2 2025 Reduced 96.35%
ARGX Argenx Se	$45.4B	$2.54 Million 0.01% of portfolio	4,611	Q2 2025 Added 40.45%
INCY Incyte Corp	$20.6B	$1.94 Million 0.01% of portfolio	28,433	Q2 2025 Added 9.25%
MRNA Moderna, Inc.	$11B	$1.62 Million 0.01% of portfolio	58,673	Q2 2025 Added 12.77%
ALNY Alnylam Pharmaceuticals, Inc.	$55.3B	$1.56 Million 0.01% of portfolio	4,775	Q2 2025 Reduced 26.92%
UTHR United Therapeutics Corp	$20.6B	$1.15 Million 0.0% of portfolio	4,016	Q2 2025 Added 9.19%
VRNA Verona Pharma PLC	$6.52B	$1.12 Million 0.0% of portfolio	11,880	Q2 2025 Added 3.43%
TECH Bio Techne Corp	$2.39B	$1.06 Million 0.0% of portfolio	20,646	Q2 2025 Added 5.18%
ASND Ascendis Pharma A/S	$11.4B	$1.04 Million 0.0% of portfolio	6,023	Q2 2025 Reduced 14.99%
BGNE Bei Gene, Ltd.	$23.5B	$866,000 0.0% of portfolio	3,824	Q2 2025 Added 10.84%
INSM Insmed Inc	$26.3B	$753,000 0.0% of portfolio	7,492	Q2 2025 Added 15.39%
SMMT Summit Therapeutics Inc.	$3.8B	$650,000 0.0% of portfolio	30,548	Q2 2025 Added 15.2%
LEGN Legend Biotech Corp	$5.4B	$530,000 0.0% of portfolio	14,937	Q2 2025 Reduced 98.51%
BMRN Biomarin Pharmaceutical Inc	$9.65B	$483,000 0.0% of portfolio	8,795	Q2 2025 Added 14.7%
EXEL Exelixis, Inc.	$12.5B	$464,000 0.0% of portfolio	10,535	Q2 2025 Added 12.49%
RNA Avidity Biosciences, Inc.	$2.55B	$463,000 0.0% of portfolio	16,316	Q2 2025 Added 4.79%
PCVX Vaxcyte, Inc.	$2.65B	$458,000 0.0% of portfolio	14,110	Q2 2025 Added 5.79%
BNTX Bio N Tech Se	$25.4B	$437,000 0.0% of portfolio	4,109	Q2 2025 Added 14.9%
BPMC Blueprint Medicines Corp	$7.73B	$319,000 0.0% of portfolio	2,495	Q2 2025 Added 19.32%
BBIO Bridge Bio Pharma, Inc.	$8.34B	$316,000 0.0% of portfolio	7,335	Q2 2025 Added 15.26%
ROIV Roivant Sciences Ltd.	$13.8B	$295,000 0.0% of portfolio	26,261	Q2 2025 Added 9.99%
RVMD Revolution Medicines, Inc.	$4.74B	$264,000 0.0% of portfolio	7,195	Q2 2025 Added 15.66%
JAZZ Jazz Pharmaceuticals PLC	$8.54B	$252,000 0.0% of portfolio	2,382	Q2 2025 Added 17.22%
HALO Halozyme Therapeutics, Inc.	$9B	$247,000 0.0% of portfolio	4,760	Q2 2025 Added 15.51%
IONS Ionis Pharmaceuticals Inc	$10.5B	$242,000 0.0% of portfolio	6,148	Q2 2025 Added 15.59%
AXSM Axsome Therapeutics, Inc.	$5.64B	$198,000 0.0% of portfolio	1,902	Q2 2025 Added 16.54%
NUVL Nuvalent, Inc.	$4.21B	$195,000 0.0% of portfolio	2,564	Q2 2025 Added 15.81%
IMVT Immunovant, Inc.	$3.55B	$181,000 0.0% of portfolio	6,603	Q2 2025 Added 11.39%
ADMA Adma Biologics, Inc.	$2.83B	$167,000 0.0% of portfolio	9,222	Q2 2025 Added 16.59%
AKRO Akero Therapeutics, Inc.	$2.5B	$164,000 0.0% of portfolio	3,079	Q2 2025 Added 15.58%
CRSP Crispr Therapeutics Ag	$4.77B	$162,000 0.0% of portfolio	3,336	Q2 2025 Added 18.42%
RYTM Rhythm Pharmaceuticals, Inc.	$5.97B	$155,000 0.0% of portfolio	2,458	Q2 2025 Added 16.16%
KRYS Krystal Biotech, Inc.	$4.85B	$153,000 0.0% of portfolio	1,116	Q2 2025 Added 15.77%
CYTK Cytokinetics Inc	$5.86B	$152,000 0.0% of portfolio	4,613	Q2 2025 Added 17.38%
PTCT Ptc Therapeutics, Inc.	$4.87B	$149,000 0.0% of portfolio	3,062	Q2 2025 Added 16.03%
ACLX Arcellx, Inc.	$3.75B	$140,000 0.0% of portfolio	2,129	Q2 2025 Added 15.77%
MRUS Merus N.V.	$4.33B	$140,000 0.0% of portfolio	2,674	Q2 2025 Added 15.66%
ACAD Acadia Pharmaceuticals Inc	$3.68B	$139,000 0.0% of portfolio	6,465	Q2 2025 Added 15.84%
PTGX Protagonist Therapeutics, Inc	$3.74B	$132,000 0.0% of portfolio	2,394	Q2 2025 Added 16.55%
RARE Ultragenyx Pharmaceutical Inc.	$2.46B	$132,000 0.0% of portfolio	3,652	Q2 2025 Added 18.0%
SRRK Scholar Rock Holding Corp	$1.45B	$129,000 0.0% of portfolio	3,668	Q2 2025 Added 15.78%
KYMR Kymera Therapeutics, Inc.	$3.31B	$109,000 0.0% of portfolio	2,516	Q2 2025 Added 15.78%
CRNX Crinetics Pharmaceuticals, Inc.	$2.33B	$104,000 0.0% of portfolio	3,619	Q2 2025 Added 16.22%
MIRM Mirum Pharmaceuticals, Inc.	$2.68B	$97,000 0.0% of portfolio	1,914	Q2 2025 Added 14.89%
XENE Xenon Pharmaceuticals Inc.	$2.7B	$92,000 0.0% of portfolio	2,964	Q2 2025 Added 15.74%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.